dantrolene sodium 250 MG Injection [Ryanodex]
- RxCUI
- 1544758
- RxNorm name
- dantrolene sodium 250 MG Injection [Ryanodex]
- Display name
- dantrolene sodium 250 MG Injection [Ryanodex]
- Full name
- dantrolene sodium 250 MG Injection [Ryanodex]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:08
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RYANODEX dantrolene sodium | DANTROLENE SODIUM | Eagle Pharmaceuticals, Inc. | 8f7b3ac0-604d-4c78-b545-5e0f8ea3d698 | 2024-10-30 | Warnings, Adverse reactions | 1544758 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 8f7b3ac0-604d-4c78-b545-5e0f8ea3d698 | dantrolene sodium 250 MG Injection [Ryanodex] | SBD | 10 | These highlights do not include all the information needed to use RYANODEX safely and effectively. See full prescribing information for RYANODEX. RYANODEX ® (dantrolene sodium) for injectable suspension, for intravenous use. Initial U.S. Approval: 1974 | 20241030 |
| 8f7b3ac0-604d-4c78-b545-5e0f8ea3d698 | Ryanodex 250 MG Injection | PSN | 10 | These highlights do not include all the information needed to use RYANODEX safely and effectively. See full prescribing information for RYANODEX. RYANODEX ® (dantrolene sodium) for injectable suspension, for intravenous use. Initial U.S. Approval: 1974 | 20241030 |
| 8f7b3ac0-604d-4c78-b545-5e0f8ea3d698 | Ryanodex 250 MG (dantrolene sodium) Injection | SY | 10 | These highlights do not include all the information needed to use RYANODEX safely and effectively. See full prescribing information for RYANODEX. RYANODEX ® (dantrolene sodium) for injectable suspension, for intravenous use. Initial U.S. Approval: 1974 | 20241030 |